Cost-Minimization Analysis of Intravitreal Aflibercept Compared with Ranibizumab on-Label In Patients with wet Age-Related Macular Degeneration (Wamd)
Abstract
Authors
ZA Murra Anton
ZA Murra Anton
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now